Chlorpheniramine Maleate Market - Forecast(2022 - 2027)

Report Code: HCR 85940 Report Format: PDF + Excel

Chlorpheniramine Maleate Market Overview

Chlorpheniramine Maleate Market size is estimated to reach $924 million by 2027, growing at a CAGR of 4.4% during the forecast period 2022-2027. Chlorpheniramine Maleate is an antiallergic medicine utilized in the treatment of different allergic conditions. It offers alleviation from runny nose, sneezing, itching, and watery eyes. Chlorphenamine (CP, CPM), also termed chlorpheniramine, is an antihistamine utilized to treat the symptoms of allergic conditions like allergic rhinitis (hay fever). It is consumed by mouth. The medicine takes impacts within 6 hours and lasts for around a day. Piriton tablets and syrup include the active ingredient chlorphenamine maleate. Investigations have indicated that the three medications fexofenadine, chlorpheniramine maleate, and Betamethasone have similar levels of efficiency in curbing the symptoms of allergic rhinitis. The physical signs have been found to be enhanced better with chlorpheniramine than the other two medications. Antihistamines are medications or other compounds that restrict the physiological impacts of histamine, utilized specifically in the treatment of allergies. Chlorpheniramine Maleate may be categorized under antihistamines. A dry mouth or xerostomia indicates a condition in which the salivary glands in the mouth do not prepare sufficient saliva to maintain the mouth wet. Xerostomia is one of the symptomatic unfavorable reactions generated by Chlorpheniramine maleate. The extensive application of ‘sedating antihistamine’ or anti-allergic termed Chlorpheniramine Maleate tablet to treat symptoms of allergies like itching nose/throat, runny nose, sneezing, or red/itchy/watery eyes is set to drive the Chlorpheniramine Maleate Market. The heightening pollution worldwide leading to allergies requiring increased application of antihistamines is set to propel the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027. This represents the Chlorpheniramine Maleate Industry Outlook.

Chlorpheniramine Maleate Market Report Coverage

The report: Chlorpheniramine Maleate Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Chlorpheniramine Maleate Market.

By Product: Injection, Syrup, Tablets, Powder.
By Application: Allergy, Hay Fever, Common Cold, Watery Eyes, Itchy Throat/Skin, Anaphylactic Shock, Rhinitis, Urticaria.
By End User: Hospitals, Clinics, Research Institutes.
By Geography: North America (the U.S, Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Chlorpheniramine Maleate Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the expanding predominance of allergic reactions requiring usage of antihistamines and the enormous count of people looking for treatment in the North American region.
  • Chlorpheniramine Maleate Market growth is being driven by the surging application of Chlorpheniramine maleate is an alkylamine antihistamine utilized in the treatment of allergic conditions like rhinitis and urticaria.  However, the dearth of awareness and side effects of Chlorpheniramine are some of the major factors hampering the growth of the Chlorpheniramine Maleate Market. 
  • Chlorpheniramine Maleate Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Chlorpheniramine Maleate Market report. 
  • For More Details on This Report - Request for Sample

Chlorpheniramine Maleate Market Share, By Product, 2021(%)

Chlorpheniramine Maleate Market


Chlorpheniramine Maleate Market Segment Analysis – By Product

The Chlorpheniramine Maleate Market based on the product can be further segmented into Injection, Syrup, Tablets, and Powder. The Injection Segment held the largest market share in 2021. This growth is owing to the growing application of Chlorpheniramine Injection in the treatment of allergic conditions. Chlorpheniramine 10 mg/ml Solution for Injection is available. The surging application of Chlorpheniramine Injection in the treatment of acute urticaria and hay fever is further propelling the growth of the Injection segment.

Furthermore, the Tablets segment is estimated to grow with the fastest CAGR of 4.8% during the forecast period 2022-2027 owing to the expanding application of Chlorpheniramine tablets for alleviation from symptoms of allergy-like sneezing, running nose, watery eyes, itching, swelling, and congestion or stiffness.

Chlorpheniramine Maleate Market Segment Analysis – By Application

The Chlorpheniramine Maleate Market based on the application can be further segmented into Allergy, Hay Fever, Common Cold, Watery Eyes, Itchy Throat/Skin, Anaphylactic Shock, Rhinitis and Urticaria. The Allergy Segment held the largest market share in 2021. This growth is owing to the surging application of Chlorpheniramine in the treatment of different allergic conditions. Chlorpheniramine performs by obstructing the activity of histamine and offers alleviation from symptoms like runny nose, sneezing, itching, skin rashes, and watery eyes. Chlorpheniramine, therefore, belongs to the group of antihistamines that provide relief from allergy and can be thus applied in the treatment of allergic patients which is further propelling the growth of this segment.

Furthermore, the Rhinitis segment is estimated to grow with the fastest CAGR of 5.0% during the forecast period 2022-2027 owing to the soaring application of Chlorpheniramine in the treatment of rhinitis and the great positive impact recorded and soaring average rating received from users of the medication.

Chlorpheniramine Maleate Market Segment Analysis – By Geography

The Chlorpheniramine Maleate Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Chlorpheniramine Maleate Market) held the largest share with 37% of the overall market in 2021. The growth of this region is owing to the increasing predominance of allergic reactions in the region resulting in the greater application of Chlorpheniramine. The presence of key players like Cardinal Health, Inc. in conjunction with the large patient pool seeking treatment is further propelling the growth of the Chlorpheniramine Maleate Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like accelerated urbanization increasing the environmental pollution in the region resulting in a greater count of cases with allergy requiring soaring application of Chlorpheniramine. The existence of a large population in countries like India is leading to bigger patient pools requiring treatment with Chlorpheniramine which is fuelling the progress of the Chlorpheniramine Maleate Market in the Asia-Pacific region.

Chlorpheniramine Maleate Market Drivers

Surging Application Of Chlorphenamine Is Projected To Drive The Growth Of Chlorpheniramine Maleate Market:

Chlorpheniramine maleate belongs to the category of first-generation antihistamines that are extensively to treat symptoms of allergic rhinitis and the common cold. Chlorpheniramine maleate seems to be an odor-free white crystalline solid or white powder with a pungent taste.  Chlorphenamine is utilized to alleviate the symptoms of hay fever, rhinitis, urticaria, and asthma. Chlorpheniramine is a histamine-H1 receptor antagonist designated for the administration of symptoms related to upper respiratory allergies. It has also been utilized in veterinary uses. One of the most extensively utilized of the classical antihistamines, it typically brings about less drowsiness and sedation than promethazine. The heightening application of Chlorphenamine is therefore fuelling the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027.

Technological Innovations Are Expected To Boost The Demand Of Chlorpheniramine Maleate:

Innovative applications involving Chlorpheniramine Maleate are likely to boost the growth of the Chlorpheniramine Maleate Market. Novel chlorpheniramine maleate (CPM) discriminatory electrochemical membranes were made by utilizing chlorpheniramine maleate-molecularly imprinted polymers. MIP was made by bulk polymerization utilizing 2-hydroxyethyl methacrylate (2-HEMA) as a monomer, ethylene glycol dimethacrylate (EGDMA) as a cross-linker, and benzoyl peroxide (BPO) as an initiator at 600C. Three CPM-MIP electrodes were built by utilizing tri-tolyl Phosphate (ToCP), tris (2- ethyl hexyl) Phosphate (TEHP), and tributyl phosphate (TBP) as plasticizers in the PVC matrix. Electrode parameters are inclusive of slopes, working concentrations ph. The interference impact in the existence of (Na+, Mg+2, Al+3, Glycine, Alanine, Arginine, and Phenylalanine) was investigated utilizing the segregated and mixed techniques to decide the selectivity coefficient determination. MIP is made by utilizing the identical composition of MIP molecularly imprinted polymer electrodes except for the template (CPM). The slopes of CMPMIP are 21.00, 21.50, and 19.08 mV/ decade, linearity range for the electrodes around. (10-5 10-1) M, the stable at a pH range from 4.0 to 8.5 and lifetime was from 30 to 10 days. The recommended electrodes were favorably used for the conclusion of CPM in certain pharmaceutical preparations, which were provided agreeable precision. These kinds of technological advancements are driving the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027.

Chlorpheniramine Maleate Market Challenges

Limitations Of Applications Of Chlorpheniramine Present Challenges To The Growth Of The Chlorpheniramine Maleate Market:

Chlorpheniramine has side effects like sleepiness or abnormal drowsiness, blurred or double vision, dry mouth, or xerostomia with rare cases of serious jaundice and serious aplastic anemia. It is not recommended for application in patients with a recognized allergy to Chlorpheniramine. It is not recommended for application in children aged less than 2 years. Chlorpheniramine is not recommended for application in patients with benign prostatic hyperplasia (enlarged prostate) owing to the raised difficulty in passage of urine. Application of Chlorpheniramine is not suggested if the patient has consumed Monoamine Oxidase (MAO) inhibitors such as selegiline or rasagiline within the previous 14 days. Their integration may raise the hazard of adverse impacts such as drowsiness and blurred vision. These issues are hampering the growth of the Chlorpheniramine Maleate Market.

Chlorpheniramine Maleate Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Chlorpheniramine Maleate Market. Key companies of this market are:

  1. Astrazeneca Plc
  2. Boc Sciences
  3. Sanofi S.A.
  4. Glaxosmithkline Plc
  5. Cardinal Health, Inc.
  6. Merck KGaA
  7. Mylan N.V.
  8. Sun Pharmaceutical Industry Limited
  9. Johnson & Johnson
  10. UCB, Inc.

Acquisitions/Product Launches:

  • In November 2021, Cardinal Health declared its business, WaveMark™ Supply Management, and Workflow Solutions, which will presently be accessible for implementation in clinical laboratories across the U.S. The role clinical laboratories play in the continuity of care is crucial: 70% of medical decisions are taken with direction from a laboratory outcome. Even before the pandemic, however, the clinical lab workforce was constrained owing to both a retreating workforce within the laboratory and an elderly population that raised testing demand.
  • In October 2021, Cardinal Health developed an interactive instrument that offers pharmacists essential advice to assist them to navigate the current Food and Drug Administration (FDA) endorsement of the earliest interchangeable biologic authorized in the U.S. The FDA endorsement was provided to the long-acting insulin termed Semglee (insulin glargine-yfgn), which is presently indicated as a biosimilar for one of the most extensively utilized and expensive biologic treatments on the market currently - insulin. The novel instrument is planned to assist pharmacies to navigate state-by-state interchangeability laws for the FDA's novel regulatory designation.
  • In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to lighten the challenges of non-obedience of medication. Outcomes transfer digital health solutions for personalized medication therapy administration, digital patient engagement, and tele-pharmacy, through its Connect™ platform. Therefore these three customer groups can enhance patient obedience to medication, fuel superior health outcomes for patients, and decrease the cost of care. Outcomes integrate numerous existing Cardinal Health businesses within Connected Care, inclusive of mscripts™, OutcomesMTM™, and TelePharm.

Related Reports

Allergy Treatment Market – Forecast (2021 - 2026)

Report Code: HCR 51422

Allergy Diagnostics Market – Forecast (2021 - 2026)

Report Code: HCR 0066

For more Lifesciences and Healthcare Market reports, please click here

1. Chlorpheniramine Maleate Market - Overview
    1.1 Definitions and Scope
2. Chlorpheniramine Maleate Market - Executive Summary
3. Chlorpheniramine Maleate Market - Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Chlorpheniramine Maleate Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Chlorpheniramine Maleate Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Chlorpheniramine Maleate Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Chlorpheniramine Maleate Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Chlorpheniramine Maleate Market – By Product (Market Size –$Million/$Billion)
    8.1 Injection
    8.2 Syrup
    8.3 Tablets
    8.4 Powder
9. Chlorpheniramine Maleate Market – By Application (Market Size –$Million/$Billion)
    9.1 Allergy
    9.2 Hay Fever
    9.3 Common Cold
    9.4 Watery Eyes
    9.5 Itchy Throat/Skin
    9.6 Anaphylactic Shock
    9.7 Rhinitis
    9.8 Urticaria
10. Chlorpheniramine Maleate Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Clinics
    10.3 Research Institutes
11. Chlorpheniramine Maleate Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Chlorpheniramine Maleate Market - Entropy
13. Chlorpheniramine Maleate Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Chlorpheniramine Maleate Market – Key Company List by Country Premium Premium
15. Chlorpheniramine Maleate Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
1.1 Injection Market 2019-2024 ($M) - Global Industry Research
1.2 Syrup Market 2019-2024 ($M) - Global Industry Research
1.3 Tablet Market 2019-2024 ($M) - Global Industry Research
1.4 Powder Market 2019-2024 ($M) - Global Industry Research
2.Global Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
2.1 Hospital Market 2019-2024 ($M) - Global Industry Research
2.2 Clinic Market 2019-2024 ($M) - Global Industry Research
2.3 Research Institute Market 2019-2024 ($M) - Global Industry Research
3.Global Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 (Volume/Units)
3.1 Injection Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Syrup Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
3.4 Powder Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Chlorpheniramine Maleate Market , By End User Market 2019-2024 (Volume/Units)
4.1 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Clinic Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Research Institute Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
5.1 Injection Market 2019-2024 ($M) - Regional Industry Research
5.2 Syrup Market 2019-2024 ($M) - Regional Industry Research
5.3 Tablet Market 2019-2024 ($M) - Regional Industry Research
5.4 Powder Market 2019-2024 ($M) - Regional Industry Research
6.North America Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
6.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
6.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
6.3 Research Institute Market 2019-2024 ($M) - Regional Industry Research
7.South America Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
7.1 Injection Market 2019-2024 ($M) - Regional Industry Research
7.2 Syrup Market 2019-2024 ($M) - Regional Industry Research
7.3 Tablet Market 2019-2024 ($M) - Regional Industry Research
7.4 Powder Market 2019-2024 ($M) - Regional Industry Research
8.South America Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
8.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
8.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
8.3 Research Institute Market 2019-2024 ($M) - Regional Industry Research
9.Europe Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
9.1 Injection Market 2019-2024 ($M) - Regional Industry Research
9.2 Syrup Market 2019-2024 ($M) - Regional Industry Research
9.3 Tablet Market 2019-2024 ($M) - Regional Industry Research
9.4 Powder Market 2019-2024 ($M) - Regional Industry Research
10.Europe Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
10.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
10.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
10.3 Research Institute Market 2019-2024 ($M) - Regional Industry Research
11.APAC Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
11.1 Injection Market 2019-2024 ($M) - Regional Industry Research
11.2 Syrup Market 2019-2024 ($M) - Regional Industry Research
11.3 Tablet Market 2019-2024 ($M) - Regional Industry Research
11.4 Powder Market 2019-2024 ($M) - Regional Industry Research
12.APAC Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
12.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
12.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
12.3 Research Institute Market 2019-2024 ($M) - Regional Industry Research
13.MENA Chlorpheniramine Maleate Market , By Dosage Form Market 2019-2024 ($M)
13.1 Injection Market 2019-2024 ($M) - Regional Industry Research
13.2 Syrup Market 2019-2024 ($M) - Regional Industry Research
13.3 Tablet Market 2019-2024 ($M) - Regional Industry Research
13.4 Powder Market 2019-2024 ($M) - Regional Industry Research
14.MENA Chlorpheniramine Maleate Market , By End User Market 2019-2024 ($M)
14.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
14.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
14.3 Research Institute Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
2.Canada Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
3.Mexico Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
4.Brazil Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
5.Argentina Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
6.Peru Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
7.Colombia Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
8.Chile Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
9.Rest of South America Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
10.UK Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
11.Germany Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
12.France Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
13.Italy Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
14.Spain Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
15.Rest of Europe Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
16.China Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
17.India Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
18.Japan Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
19.South Korea Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
20.South Africa Chlorpheniramine Maleate Market Revenue, 2019-2024 ($M)
21.North America Chlorpheniramine Maleate By Application
22.South America Chlorpheniramine Maleate By Application
23.Europe Chlorpheniramine Maleate By Application
24.APAC Chlorpheniramine Maleate By Application
25.MENA Chlorpheniramine Maleate By Application
26.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck Kgaa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Ucb, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Mylan N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Boc Science, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Sun Pharmaceutical Industry Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Cardinal Health, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)